Inventor
CUENOUD BERNARD
GB28 patents
⚠️ This page may combine multiple inventors who share the name “CUENOUD BERNARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
12 patentsUS6878721B1Apr 12, 2005
Beta2-adrenoceptor agonists
NOVARTIS AG29 citations96
US6800643B2Oct 5, 2004
Mixtures for organic compounds for the treatment of airway diseases
NOVARTIS AG59 citations95
US6537524B1Mar 25, 2003
Combinations of formoterol and a tiotropium salt
NOVARTIS AG96 citations94
US7622483B2Nov 24, 2009
β2-adrenoceptor agonists
NOVARTIS AG8 citations92
US6921757B2Jul 26, 2005
Organic compounds
NOVARTIS AG34 citations90
US7820694B2Oct 26, 2010
Beta-2-adrenoreceptor agonists
NOVARTIS AG5 citations73
US7008951B2Mar 7, 2006
Mixtures or organic compounds for the treatment of airway diseases
NOVARTIS AG5 citations73
US6670468B1Dec 30, 2003
2′-substituted nucleosides and oligonucleotide derivatives
NOVARTIS AG12 citations73
US7745462B2Jun 29, 2010
Quinoline-2-one derivatives for the treatment of airways diseases
NOVARTIS AG7 citations71
US7622484B2Nov 24, 2009
Mixtures or organic compounds for the treatment of airway diseases
NOVARTIS AG1 citations61
US9040559B2May 26, 2015
BETA2-adrenoceptor agonists
NOVARTIS AG0 citations52
US8017608B2Sep 13, 2011
5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
NOVARTIS AG0 citations36
NESTLE SA
8 patentsUS11857527B2Jan 2, 2024
Medium chain triglyceride compositions
NESTLE SA1 citations69
US12576062B2Mar 17, 2026
Methods using administration of medium chain triglycerides (MCT) prior to a meal to increase ketone production from the MCTs
NESTLE SA0 citations62
US12544351B2Feb 10, 2026
Methods using medium chain triglycerides administered prior to a meal to decrease postprandial glucose from the meal
NESTLE SA0 citations62
US12527761B2Jan 20, 2026
Mixed triglycerides
NESTLE SA0 citations58
US12251367B2Mar 18, 2025
Medium chain triglyceride compositions
NESTLE SA0 citations58
US12582627B2Mar 24, 2026
MCT formulations for improving cognitive functions
NESTLE SA0 citations53
US12403152B2Sep 2, 2025
Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursor
NESTLE SA0 citations53
US12544397B2Feb 10, 2026
Compositions and methods containing N-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions
NESTLE SA0 citations51
CUENOUD BERNARD
5 patentsUS8796307B2Aug 5, 2014
Beta2-adrenoreceptor agonists
CUENOUD BERNARD5 citations83
US8067437B2Nov 29, 2011
Beta-2-adrenoreceptor agonists
CUENOUD BERNARD7 citations83
US8283362B2Oct 9, 2012
Beta-2-adrenoreceptor agonists
CUENOUD BERNARD5 citations72
US8658673B2Feb 25, 2014
BETA2-adrenoreceptor agonists
CUENOUD BERNARD2 citations62
US8436017B2May 7, 2013
Beta-2-adrenoreceptor agonists
CUENOUD BERNARD0 citations51